In vitro Effect of Silver Nanoparticles on Blastocystis hominis

Int J Nanomedicine. 2020 Oct 22:15:8167-8173. doi: 10.2147/IJN.S272532. eCollection 2020.

Abstract

Introduction: This study aims to assess the efficacy of silver nanoparticles (Ag Nps) alone and combined with metronidazole (Ag Nps + MTZ) as potential alternative therapeutic agents for Blastocystis hominis.

Methods: The parasites were challenged with Ag Nps, Ag Nps + MTZ and MTZ. To assess the efficacy of drugs, counting of viable parasites was done after 1, 2, and 3 hours of adding the drugs.

Results: Blastocystis hominis count was reduced by 20.72%, 28.23%, and 18.92% after one hour of adding Ag Nps, Ag Nps + MTZ, and MTZ, respectively. Cysts count was further reduced by 51.49%, 61.61%, and 40.78% after 2 hours and by 71.69%, 79.67%, and 62.65% after 3 hours of adding the drugs in the same order, respectively.

Conclusion: There was a statistically significant difference (P<0.05) in the in vitro growth inhibition of the parasite over the different time intervals when using the tested drugs against the control drug.

Keywords: Blastocystis hominis; eosin brilliant cresyl blue stain; metronidazole; silver nanoparticles.

MeSH terms

  • Antiprotozoal Agents / chemistry*
  • Antiprotozoal Agents / pharmacology*
  • Blastocystis hominis / drug effects*
  • Blastocystis hominis / growth & development
  • Drug Interactions
  • Humans
  • Metal Nanoparticles*
  • Metronidazole / pharmacology
  • Silver / chemistry*
  • Silver / pharmacology*

Substances

  • Antiprotozoal Agents
  • Metronidazole
  • Silver

Grants and funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.